A Daunting and Challenging Task to Prove the Effectiveness of Reducing Acute Exacerbation in COPD Patients with Type 2 Diabetes by GLP-1 Receptor Agonists

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (No.82170043)
  • State Key Laboratory of Respiratory Disease (SKLRD-OP-202305)
  • National Natural Science Foundation of China (No.82170043)
  • State Key Laboratory of Respiratory Disease (SKLRD-OP-202305)

This publication has 7 references indexed in Scilit: